Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • Alphaアッセイ
  • AlphaLISA SureFire Ultra Human α-Synuclein Aggregation Kit, 500 Assay Points

AlphaLISA SureFire Ultra Human α-Synuclein Aggregation Kit, 500 Assay Points

AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
Video Play Button View All
AlphaLISA SureFire Ultra Human α-Synuclein Aggregation Kit, 500 Assay Points
AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
Video Play Button
Video Play Button
Video Play Button
AlphaLISA SureFire Ultra aggregated

The AlphaLISA™ SureFire® Ultra™ alpha synuclein aggregation assay kit can be used to measure levels of aggregated alpha-synuclein in cellular lysates using no-wash Alpha technology. The antibodies recognize distinct epitopes specific to the Aggregated form of α-Synuclein.

View product information
Feature Specification
Application タンパク質定量
Sample Volume 10 µL

The AlphaLISA™ SureFire® Ultra™ alpha synuclein aggregation assay kit can be used to measure levels of aggregated alpha-synuclein in cellular lysates using no-wash Alpha technology. The antibodies recognize distinct epitopes specific to the Aggregated form of α-Synuclein.

View product information
Product variants
Unit Size: 500 assay points
Part #:
ALSU-AASYN-A500
Unit Size: 10,000 assay points
Part #:
ALSU-AASYN-A10K
Unit Size: 50,000 assay points
Part #:
ALSU-AASYN-A50K
Unit Size: 100 assay points
Part #:
ALSU-AASYN-A-HV
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
Video Play Button
Video Play Button
Video Play Button
AlphaLISA SureFire Ultra Human α-Synuclein Aggregation Kit, 500 Assay Points
AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
AlphaLISA SureFire Ultra aggregated
AlphaLISA SureFire Ultra Detection Kit
Video Play Button
Video Play Button
Video Play Button
AlphaLISA SureFire Ultra aggregated

Loading...

Quick links
  • Variants
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Get help

Product information

  • Overview
  • How it works
  • Specifications
  • Video gallery

Overview

α-Synuclein is a neuronal protein encoded by the SNCA gene that regulates synaptic vesicle trafficking and subsequent neurotransmitter release. α-Synuclein is a prominent component of intracellular fibrillary aggregates in the brains of patients suffering from synucleinopathies. This protein represents a key molecular hallmark for Parkinson’s disease, dementia with Lewy bodies, or multiple system atrophy. The extensive phosphorylation of α-Synuclein on Ser129 is also associated with a pathological event.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 µL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 µL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 µL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 µL reaction volume.

In the AlphaLISA™ SureFire® Ultra™ assay, Donor beads are coated with streptavidin to capture one of the antibodies, which is biotinylated. Acceptor beads are coated with a proprietary CaptSure™ agent that immobilizes the other antibody, labeled with a CaptSure™ tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor beads close together, generating signal. The amount of light emission is directly proportional to the amount of phosphoprotein present in the sample.

AlphaLISA™ SureFire® Ultra™ kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies

Alpha SureFire® kits can be used for:

  • Detecting alpha synuclein aggregation
  • Cellular kinase assays
  • Receptor activation studies
  • Screening
  • Replacing an alpha synuclein ELISA kit

How it works

AlphaLISA SureFire Ultra protein dimer / aggregate detection assay principle

The AlphaLISA SureFire Ultra dimer/aggregate assay measures the levels of a given protein in a dimeric, multimeric or any other aggregated form in a biological sample (e.g. cell lysate).

The assay uses a single antibody clone tagged with both CaptSure™ peptide and biotin, that recognizes exposed epitopes on the multivalent target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure agent to specifically immobilize the antibody labeled with a CaptSure tag. Donor Beads are coated with streptavidin to capture the same specific antibody, which is biotinylated. In the presence of the multivalent protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of multimeric protein present in the sample.

assay principle Aggregate AlphaLISA Surefire Ultra

 

AlphaLISA SureFire Ultra dimer / aggregate detection two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of dimer or aggregate AlphaLISA SureFire Ultra detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2plates assay protocol AlphaLISA Surefire Ultra Aggregate assay

AlphaLISA SureFire Ultra protein dimer / aggregate detection one-plate assay protocol

Detection of the dimer or aggregate with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire Ultra quality.

1plate assay protocol AlphaLISA Surefire Ultra Aggregate assay

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA SureFire Ultra
Detection Modality
Alpha
Lysis Buffer Compatibility
Lysis Buffer
Product Group
Kit
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
Alpha-synuclein
Target Class
Biomarkers
Target Species
Human
Technology
Alpha
Therapeutic Area
Central Nervous System
Unit Size
500 assay points

Video gallery

Video Play Button
Video Play Button
Video Play Button
AlphaLISA SureFire Ultra Human α-Synuclein Aggregation Kit, 500 Assay Points
Video Play Button
Video Play Button
Video Play Button

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Application Note:-:2
  • Brochure:-:2
  • Guide:-:1
  • Literature - Publication Review:-:1
  • Whitepaper:-:1
1-1 of 1 Resources
Whitepaper Icon
Whitepaper
Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases

Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading...

Learn more

Loading...

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.